Paul J. Tiseo
Hoofd Techniek/Wetenschap/O&O bij COGNITION THERAPEUTICS, INC.
Actieve functies van Paul J. Tiseo
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| COGNITION THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 11-10-2022 | - |
Loopbaan van Paul J. Tiseo
Eerdere bekende functies van Paul J. Tiseo
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CENTREXION THERAPEUTICS CORPORATION | Corporate Officer/Principal | - | - |
Opleiding van Paul J. Tiseo
| Stony Brook University | Undergraduate Degree |
| Lewis Katz School of Medicine | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
Operationeel
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| COGNITION THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Centrexion Therapeutics Corp.
 Centrexion Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Centrexion Therapeutics Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, developing, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of chronic pain. Its product pipeline includes CNTX-4975, CNTX-0290, CNTX-6970, CNTX-2022, CNTX-6016, and intrathecal platform. The company was founded by Sol J. Barer and Jeffrey B. Kindler in February 2013 and is headquartered in Boston, MA. | Health Technology |
- Beurs
- Insiders
- Paul J. Tiseo
- Ervaring
